Dr. Nissen discusses a new class of drugs approved by the FDA called PCSK9 inhibitors for cholesterol lowering, how they are administered, side effects and who they are indicated and approved for.
➨ Visit Cleveland Clinic: [ Ссылка ]
➨ Visit Health Hub from Cleveland Clinic: [ Ссылка ]
➨ Subscribe to our YouTube Channel: [ Ссылка ]
➨ Like Cleveland Clinic on Facebook: [ Ссылка ]
➨ Follow Cleveland Clinic on Twitter: [ Ссылка ]
➨ Follow Cleveland Clinic on Google+: [ Ссылка ]
➨ Follow Cleveland Clinic on Instagram: [ Ссылка ]
➨ Connect with Cleveland Clinic on LinkedIn: [ Ссылка ]
➨ Follow Cleveland Clinic on Pinterest: [ Ссылка ]
